Copeland buys 98,984 shares in U.S. Physical Therapy stock

Published on 10/20/2026 at 13:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Copeland Capital raised its stake 11.8 percent by buying 98,984 shares on October 14, 2026. U.S. Physical Therapy stock costs EUR 74.75 on October 20, 2026.

Ownership and earnings dates

Copeland Capital bought 98,984 shares on October 14, 2026.
Second-quarter 2026 revenue reached USD 214.06 million, up 8.5 percent year over year.
U.S. Physical Therapy stock trades at EUR 74.75 at 1:07 p.m. CEST at Lang & Schwarz on October 20, 2026.

USPH, US90337L1089, Illustration mit AI erstellt.

U.S. Physical Therapy (US90337L1089) attracted a 98,984-share purchase by Copeland Capital Management on October 14, 2026, according to MarketBeat. The fund increased its stake 11.8 percent to 940,528 shares, equal to 6.3 percent of the company. U.S. Physical Therapy's second-quarter 2026 revenue reached USD 214.06 million, up 8.5 percent year over year, while earnings per share came in at USD 0.75 against a USD 0.81 consensus estimate, MarketBeat reported.

What does the purchase mean?

The filing gives institutional ownership a fresh figure. Copeland's position was valued at USD 80.6 million at the end of the third quarter of 2026, and the fund's purchase added 98,984 shares to its holdings. The same report listed a quarterly dividend of USD 0.46 per share and a 2.1 percent yield.

Analyst targets remain higher

MarketBeat said Barrington Research raised its target from USD 90.00 to USD 98.00 on August 10, 2026, while JPMorgan lifted its target from USD 90.00 to USD 95.00 on September 11, 2026. The report also cited a consensus target of USD 98.25 from seven analysts. That upside view sits alongside the second-quarter earnings miss, which leaves operating growth and profit conversion as the central investor questions.

Three dated signals for USPH

MarketBeat recorded Barrington Research's target increase from USD 90.00 to USD 98.00 on August 10, 2026. MarketBeat recorded JPMorgan's target increase from USD 90.00 to USD 95.00 on September 11, 2026. Copeland Capital then bought 98,984 shares on October 14, 2026, according to MarketBeat.

Next reporting date is November 4

U.S. Physical Therapy's next earnings date is November 4, 2026, according to Yahoo Finance. The appointment calendar gives investors a defined checkpoint for testing whether the 8.5 percent revenue growth recorded in the second quarter is translating into stronger earnings.

USPH valuation and trading snapshot

U.S. Physical Therapy operates outpatient physical therapy clinics and industrial injury prevention services. Its primary listing is on the NYSE, and the company had a market capitalization of USD 1.3 billion and a 52-week range of USD 58.19 to USD 93.50 as of October 19, 2026. The stock was trading at EUR 74.75 at Lang & Schwarz on October 20, 2026 at 1:07 p.m. CEST.